Le Lézard
Classified in: Business
Subjects: STOCK/OTHER MARKET NEWS, v

Core Canadian Dividend Trust Declares Monthly Fund Distribution


TORONTO, Dec. 04, 2019 (GLOBE NEWSWIRE) -- (TSX: CDD.UN) Core Canadian Dividend Trust declares a monthly fund distribution in the amount of $0.03077 per unit, payable on December 31, 2019 to unitholders of record on December 13, 2019.

For further information, please contact Investor Relations at 416.681.3966, toll free at 1.800.725.7172, email at [email protected] or visit www.strathbridge.com.

John Germain, Senior Vice-President & CFO

 
Strathbridge Asset Management Inc.
121 King Street West
Suite 2600
Toronto, Ontario, M5H 3T9

Commissions, trailing commissions, management fees and expenses all may be associated with investment funds. Please read the prospectus before investing. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated.


These press releases may also interest you

at 08:15
YETI Holdings, Inc. ("YETI") today announced that it plans to report its first quarter fiscal year 2024 financial results on Thursday, May 9, 2024, before the market opens. YETI will host a conference call at 8:00 a.m. ET to discuss its financial...

at 08:15
AdaptHealth Corp. ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2024 financial...

at 08:15
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 second quarter ended...

at 08:15
GE Vernova Inc. is scheduled to announce its first quarter 2024 financial results on Thursday, April 25, 2024, before market open. The company will host a webcast to discuss its financial results at 7:30 AM ET, which can be accessed at...

at 08:11
With the fourth block reward halving around the corner for BTC and BSV, there will be increased focus from miners regarding the scaling potential of blockchain technology, with a focus on revenue, cost efficiencies, and sustainability....

at 08:10
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ending March 31, 2024 on Thursday, May 2, 2024, before the U.S. financial markets open. Management...



News published on and distributed by: